2017
567 Therapeutic Immunosuppression Concentrations on Day 0 and the Development of Acute Graft Versus Host Disease (GVHD) in Hematopoietic Stem Cell Transplantation (HSCT)
Mohamed S, Perreault S, Seropian S, Isufi I, Foss F, Cooper D. 567 Therapeutic Immunosuppression Concentrations on Day 0 and the Development of Acute Graft Versus Host Disease (GVHD) in Hematopoietic Stem Cell Transplantation (HSCT). Transplantation And Cellular Therapy 2017, 23: s395-s396. DOI: 10.1016/j.bbmt.2016.12.616.Peer-Reviewed Original Research
2010
Brain Natriuretic Peptide (BNP) Elevations In Allogeneic Stem Cell Transplant (ASCT) Recipients at the Time of WBC Engraftment. Correlation with Engraftment Syndrome and Cardiac Dysfunction.
Isufi I, Barile A, Russell K, Hryniewicz K, Baker J, Medoff E, Jacoby D, Lee F, Foss F, Cooper D, Seropian S. Brain Natriuretic Peptide (BNP) Elevations In Allogeneic Stem Cell Transplant (ASCT) Recipients at the Time of WBC Engraftment. Correlation with Engraftment Syndrome and Cardiac Dysfunction. Blood 2010, 116: 1309. DOI: 10.1182/blood.v116.21.1309.1309.Peer-Reviewed Original ResearchHigher cumulative anthracycline doseCumulative anthracycline doseEngraftment syndromeAnthracycline doseWBC engraftmentPercent of ptsDay 0Pg/ASCT recipientsHD-CYHigher BNPCardiac complicationsElevated BNPCardiac dysfunctionIntensity conditioningOne-year non-relapse mortalityAllogeneic stem cell transplant recipientsBrain natriuretic peptide elevationIncidence of ESStem cell transplant recipientsWeight gainAcute cardiac complicationsHistory of HTNMore diagnostic criteriaNatriuretic peptide elevation